After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
The antibacterial drug is approved to treat travelers’ diarrhea, which is defined as having 3 or more unformed stools in 24 hours, in a person who is traveling.
In an FDA statement, Scott Gotlieb, MD, discusses the pathogen added to the list of foodborne pathogens to routinely test for, why it was added, and the FDA’s ongoing efforts to screen domestic and imported...
With concerns of bioterrorism in mind, the US Food and Drug Administration has approved the first drug with an indication for the treatment of smallpox.
The FDA has expanded the indication for a drug formerly approved for the treatment of patients with complicated intra-abdominal infections and complicated urinary tract infections.
